McKesson (NYSE:MCK) shares got a bump in after-hours trading yesterday when it reported strong 3rd-quarter results and announced the $918 million acquisition of a chain of independent pharmacies in Canada.
The San Francisco-based HIT software and pharmaceuticals distributor posted profits of $300.0 million, or $1.20 per diluted share, on sales of $30.84 billion for the 3 months ended Dec. 31, 2011. That’s a top-line jump of 9.2% and a whopping 93.5% increase for its bottom line, compared with Q3 2010, when McKesson logged profits of $155.0 million, or 60 cents diluted EPS, on sales of $28.25 billion.
Excluding 1-time items, adjusted earnings were $1.40 per share. Analysts on Wall Street were expecting adjusted EPS of $1.38.
Sign up to get our free newsletters delivered straight to your inbox
McKesson also said it’s acquiring the pharmacies business of Katz Group Canada for $920 million Canadian.
“McKesson delivered another quarter of solid operating results, and I am pleased with our accomplishments during the first nine months of our fiscal year,” chairman & CEO John Hammergren said in prepared remarks. “Based on our year-to-date progress, we continue to expect adjusted earnings between $6.19 and $6.39 per diluted share for the fiscal year ending March 31, 2012.”
Align Technology slumps after posting 2011 earnings slide
Shares of Align Technology (NSDQ:ALGN) slumped in after-hours trading yesterday when it reported a double-digit profit decline for 2011, despite posting strong 4th-quarter numbers
The San Jose, Calif.-based dental device maker posted profits of $66.7 million, or 83 cents per share, on sales of $479.7 million last year. That’s a 23.9% sales gain but a 10.2% profit slide, compared with earnings of $74.3 million, or 95 cents diluted EPS, on sales of $387.1 million during 2010.
For the 4th quarter, Align logged profits of $20.4 million, or 25 cents diluted EPS, on sales of $128.9 million, up 106.5% and 38.8%, respectively, compared with the same period last year. Adjusted for 1-time items, Q4 EPS reached 28 cents, beating analysts’ expectations of 22 cents EPS. Full-year adjusted EPS were 97 cents, again beating The Street’s consensus forecast of 90 cents adjusted EPS.
ALGN shares were down 6.6% to $23.70 as of about 8 p.m. yesterday. Read more
Hologic’s Q1 results beat The Street
Women’s health products maker Hologic (NSDQ:HOLX) reported a Street-beating 1st quarter and reaped the reward after hours, when investors sent shares up more than 7% at one point.
The Bedford, Mass.-based firm posted profits of $20.8 million, or 8 cents per share, on sales of $472.7 million during the 3 months ended Dec. 24, 2011.
That’s a 9.3% addition to the top line and a 90.2% earnings increase compared with profits of $10.9 million, or 4 cents diluted EPS, on sales of $432.6 million during the same period last year.
Analysts were looking for adjusted EPS of 32 cents, which Hologic handily beat with its 34-cent adjusted EPS figure. Read more
ICU Medical’s Q4, 2011 numbers top Wall Street
Sales and earnings grew during the 4th quarter and full-year 2011 for ICU Medical (NSDQ:ICUI) and it beat Wall Street’s expectations, but still lost ground in after-hours trading.
The San Clemente, Calif.-based medical device maker posted Q4 profits of $17.8 million, or $1.22 per share, on sales of $76.5 million during the 3 months ended Dec. 31, 2011.
That compares with profits of $10.0 million, or 72 cents per share, on sales of $75.6 million during the same period last year. Adjusted to exclude 1-time items, EPS reached 79 cents, well above Wall Street’s call of 62 cents.
That wasn’t enough to buoy ICUI shares after hours, however, when investors on The Street sent share prices down 4.0% to $44 as of about 7:30 p.m.
For the full year, ICU Medical logged profits of $44.7 million, or $3.15 diluted EPS, on sales of $302.2 million – up 44.7% and 6.2%, respectively. Read more
